Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.

Objectives: To characterize the population pharmacokinetics of the rilpivirine long-acting (LA) formulation after intramuscular administration.Methods: Rich and sparse rilpivirine plasma concentration data were obtained from seven clinical studies. In total, 18 261 rilpivirine samples were collected...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Antimicrobial Chemotherapy (JAC) Vol. 76; no. 12; pp. 3255 - 3263
Autores principales: Neyens, M, Crauwels, H M, Perez-Ruixo, J J, Rossenu, S
Formato: research Journal Article
Publicado: Oxford University Press / USA Dec2021
Acceso en línea:Ver este registro en EBSCOhost